Prevalence of Hepatitis A in Iranian Patients with Chronic Liver Disease
Authors
Ahmad Shavakhi1, Mohammad Hossein Somi1,*, Sara Farhang1, Golnar Majidi1, Taraneh Majidi1, Ali Asghar Pouri1
1Liver and Gastrointestinal Diseases Research Center (LRGDC), Tabriz University of Medical Sciences, Tabriz, IR Iran
*Corresponding Author: Liver and Gastrointestinal Diseases Research Center (LRGDC), Tabriz University of Medical Sciences, Tabriz, IR Iran. Email:, mhosseinsina@yahoo.com. Email: mhosseinsina@yahoo.com
Archives of Clinical Infectious Diseases:Vol. 3, issue 4; 189-192
Published online:Oct 31, 2008
Article type:Research Article
How to Cite:Shavakhi A, Somi MH, Farhang S, Majidi G, Majidi T, et al. Prevalence of Hepatitis A in Iranian Patients with Chronic Liver Disease. Arch Clin Infect Dis. 2008;3(4):. doi:
Abstract
Background:
Acute hepatitis A in patients with chronic liver diseases (CLD) may lead to a more severe outcome for which routine vaccination is recommended in many regions. Nevertheless, studies of HAV seroprevalence and exposure predictors in populations with CLD are scanty in our region.
Patients and methods:
We studied 200 patients with CLD between September 2005 and September 2006. Patients were stratified on the basis of age, gender, size of family, place of residency and etiology of liver disease. The HAV seroprevalence in patients with CLD was compared with age- and sex-matched controls. Independent predictors of HAV exposure were identified by logistic regression analysis.
Results:
Of 200 patients, HAV seroprevalence was available for 190 (96.5%). Hepatitis B and C, alcohol, autoimmune hepatitis and Wilsons disease were the causes of CLD. Most of the seronegative patients aged 10-20 years. The overall HAV seroprevalence was 97.3% in controls. None of the risk factors were identified as independent predictors.
Conclusion:
Age stratified seroprevalence of HAV in patients with CLD is close to that of the general population. High prevalence of HAV must be considered in vulnerable travelers to our country.
Somi M, Farhang S, Majid G, Shavakhi A, Pouri A. Seroprevalence of Hepatitis E in Patients with Chronic Liver Disease from East Azerbaijan, Iran. Hepat Mon. 2007;7(3):. doi:
Esmaeilidooki MR, Moslemi L, Rezai A, Tirtashi MS, Sharbatdaran M, et al. The Trend of Hepatitis A Epidemiology in Children, Based on Two Studies in the North of Iran. J Compr Ped. 2014;5(3):e16270. doi: https://doi.org/10.17795/compreped.16270
Amiri H, Mohammadi MJ, Farhadi M, Zahiri N, Ghanbari S, et al. The Incidence of Hepatitis A and the Variables Influencing the Outbreak in Southwest Iran Over Ten Years (2013 - 2023). Hepat Mon. 2025;25(1):e165205. doi: https://doi.org/10.5812/hepatmon-165205
Nazer MR, Beiranvand B, Obeidavi Z, Beiki O. Prevalence of hepatitis C genotypes in patients with hepatitis C in Lorestan province (2009-2013). J Kermanshah Univ Med Sci. 2014;18(2):e74169. doi: https://doi.org/10.22110/jkums.v18i2.1358
Hashemi S, Jalali F, Hajiani E. Seroprevalence of Delta Hepatitis in Patients with Chronic Hepatitis B and its Clinical Impact in Khuzestan Province, Southwest Iran. Hepat Mon. 2009;9(4):. doi: